Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant MYOD1 anticorps (AA 1-100)

L’anticorps anti-MYOD1 Monoclonal Lapin est utilisé pour la détection de MYOD1 dans des échantillons de Humain. Il a été validé pour IHC.
N° du produit ABIN7857888
687,58 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour Recombinant MYOD1 anticorps (AA 1-100) (ABIN7857888)

Antigène

Voir toutes MYOD1 Anticorps
MYOD1 (Myogenic Differentiation 1 (MYOD1))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 183
  • 82
  • 76
  • 32
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 113
  • 74
  • 1
Lapin

Clonalité

  • 120
  • 68
  • 1
Monoclonal

Conjugué

  • 100
  • 11
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp MYOD1 est non-conjugé

Application

  • 97
  • 66
  • 50
  • 45
  • 43
  • 21
  • 19
  • 18
  • 18
  • 18
  • 12
  • 10
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

MYOD1-9405R
  • Épitope

    • 16
    • 14
    • 11
    • 10
    • 9
    • 9
    • 6
    • 6
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-100

    Fonction

    Recombinant MyoD1 (Rhabdomyosarcoma Marker) Antibody

    Specificité

    MyoD1, one of the MyoD family of myogenic helix-loop-helix transcription factors, combined with myogenin, plays a role in coordinating the myogenic differentiation pathway from the determination of mesodermal precursors into myoblasts, the differentiation of myoblasts into myotubes, and finally the maturation of myotubes into skeletal myofibers. Normal mature skeletal muscle does not express MyoD1 protein. MyoD1 is expressed in myoblasts before differentiation while myogenin has post-differentiation functions. Anti-MyoD1 immunostaining identifies cells committed to myogenesis in their earliest phase, thus, it is a better biomarker for less differentiated Rhabdomyosarcomas (RMS). RMS are the most frequent malignant soft tissue neoplasms of childhood. While better differentiated RMS have cross-striations or rhabdomyoblasts that allow for a confident morphologic diagnosis, less differentiated RMS resemble other small blue round-cell tumors. Studies suggest, anti-MyoD1 may be used together with anti-Myogenin and anti-Desmin as a panel of markers since any RMS is virtually never negative for all three markers simultaneously.

    Purification

    200ug/ml of Ab purified by Protein A Column.

    Immunogène

    Recombinant fragment (around aa1-100) of human MyoD1 protein (exact sequence is proprietary)

    Isotype

    IgG, kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Antigène

    MYOD1 (Myogenic Differentiation 1 (MYOD1))

    Autre désignation

    MyoD1

    Sujet

    bHLHc1, Class C basic helix-loop-helix protein 1, Myoblast determination protein 1, Myogenic differentiation 1, Myogenic factor 3 (Myf-3), Myogenin D1, PUM

    Human fetal skeletal muscle or rhabdomyosarcoma.

    Poids moléculaire

    45kDa

    ID gène

    4654, 181768

    UniProt

    P15172

    Pathways

    Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
Vous êtes ici:
Chat with us!